Ireland· IE-PA-PA0126/312/002
Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Clonmel 40 mg/5 mg/12.5 mg film-coated tablets
A olmesartan medoxomil, amlodipin und hydrochlorothiazid product containing olmesartan medoxomil + amlodipine + hydrochlorothiazide, registered in Ireland by Clonmel Healthcare Ltd. The same ATC class is registered in 9 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Olmesartan medoxomil, amlodipin und hydrochlorothiazid is registered in 9 of 19 countries.
Countries holding a registration under ATC C09DX03 (olmesartan medoxomil, amlodipin und hydrochlorothiazid), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Olmesartan medoxomil, amlodipin und hydrochlorothiazid · ATC C09DX03
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Olmesartan medoxomil + Amlodipine + Hydrochlorothiazide
- Manufacturer
- Clonmel Healthcare Ltd
- Country
- Ireland (IE)
- ATC code
- C09DX03
- ATC class
- Olmesartan medoxomil, Amlodipin und Hydrochlorothiazid
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0126/312/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
36 interactions on record for olmesartan medoxomil, amlodipin und hydrochlorothiazid.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Olmesartan medoxomil, amlodipin und hydrochlorothiazid · interactions on record
36 records
36 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Olmesartan medoxomil, amlodipin und hydrochlorothiazid in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSINTONYN COMBIMenarini International Operations Luxembourg S.A., Luxembourg
- United Statesolmesartan medoxomil / amlodipine besylate / hydrochlorothiazideREMEDYREPACK INC.
- GermanyOlmeamlo HctTad Pharma Gmbh
- FinlandAlea CompMenarini International Operations Luxembourg S.A.
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Amelior Plus Hct
- Belgium · Forzaten/Hct, Olmesartan/Amlodipin/Hct Viatris
- Bulgaria · Олмезид Трио, Олместа А Плюс
- Cyprus · Olmedipin Plus, Orizal Plus
- Czechia · Sintonyn Combi
- Germany · Olmeamlo Hct, Olmeamlodipinhct Puren
- Estonia · Gaduar, Olmesartan Medoxomil/Amlodipine/Hct Accord
- Spain · Albis Plus, Balzak Plus
- United Kingdom (Northern Ireland) · Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide Milpharm, Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide Milpharm Limited
- Greece · Comprelan Plus, Gaduar
- Croatia · Omelia
- Hungary · Duactan Hct
- Italy · Gaduar, Olmesartan, Amlodipina E Idroclorotiazide Eg
- Lithuania · Gaduar, Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide Accord
- Luxembourg · Forzaten/Hct, Olmesartan/Amlodipin/Hct Viatris
- Latvia · Gaduar, Olmesartan Medoxomil/Amlodipine/ Hydrochlorothiazide Accord
- Malta · Konverge Plus
- Netherlands · Belfor Hct, Capenon Hct
- Poland · Amolisa Hct, Elestar Hct
- Portugal · Amlodipina + Olmesartan Medoxomilo + Hidroclorotiazida Alter, Amlodipina + Olmesartan Medoxomilo + Hidroclorotiazida Generis
- Romania · Inovum Hct, Sevikar Hct
- Slovenia · Olectan Hct, Olsitri
- Slovakia · Folgan Hct
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ce735c56-110b-4bc6-91de-b6c6295c8121 GET /v1/drugs/ce735c56-110b-4bc6-91de-b6c6295c8121?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"C09DX03"
],
"strength": null,
"pa_number": "PA0126/312/002",
"substances": [
"Olmesartan medoxomil",
"Amlodipine",
"Hydrochlorothiazide"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "24/07/2020",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about olmesartan medoxomil, amlodipin und hydrochlorothiazid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.